Table 2. Prevalence of drug interactions in hospitalized patients.
Author, year | Sample | Sample size | Average of number of drugs per patient | Prevalence of clinically manifested DDIs [%] (95% CI) |
---|---|---|---|---|
Herr et al., 1992 | Patients | 340 | NR | 1.5 (0.6–3.4) |
Egger et al., 2003 | Patients | 163 | NR | 14.7 (10.1–21.0) |
Blix et al., 2008 | Patients | 827 | 4.8 | 8.8 (7.1–11.0) |
Fokter et al., 2009 | Patients | 323 | 5.0 | 1.2 (0.5–3.1) |
Ray et al., 2010 | Patients | 400 | 9.0 | 64.0 (59.2–68.6) |
Muñoz-Torrero et al., 2010 | Patients | 405 | 5.0 | 26.4 (22.4–30.9) |
Marusic et al., 2013 | Patients | 222 | NR | 9.5 (6.3–14.0) |
De Paepe et al., 2013 | Patients | 82 | 5.0 | 18.3 (11.4–28.0) |
Bucşa et al., 2013 | Patients | 305 | 4.0 | 3.6 (2.0–6.4) |
Marino et al., 2016 | Patients | 3473 | NR | 5.6 (4.9–6.4) |
NR—Not reported.